24
Jun
2025

Porton Pharma Solutions Ltd

Exhibitor at CPHI & PMEC China 2025 stand E2A32, Contract Services
About Us

With over 5,000 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecule APIs, dosage forms and biologics. By efficiently advancing development and enabling commercialization of multiple high-impact therapies, Porton is proud to have earned the trust of some of the world’s leading and most innovative pharmaceutical companies in the world.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Contract Service
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2025
  • 24 Jun 2025 - 26 Jun 2025
  • Shanghai New International Expo Center
  • Visit us at stand E2A32, Contract Services

Products Featured at CPHI & PMEC China 2025

  • Conjugates CDMO

    Product Conjugates CDMO

  • API CDMO Service

    Product API CDMO Service

    API CDMO Service
  • Biologics CDMO Service

    Product Biologics CDMO Service

    Gene and Cell Therapy Service  Porton provides world-class process development and manufacturing services for DNA plasmids, viral vectors and cell therapeutics e.g. Car-T backed by state of the art laboratories including BSL-2 laboratories high-quality cGMP production assets operated to global regulat...
  • Drug Product CDMO Service

    Product Drug Product CDMO Service

    Synergizing with US site for global clients, Porton has established end-to-end drug product CDMO platform, integrating global experts and formulation development technologies. The core technology team has experience of over 30 years in big pharma companies and drug product industry. The core R&D, techn...